Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $7.15 billion. The enterprise value is $6.35 billion.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.08 million shares outstanding. The number of shares has increased by 13.83% in one year.
| Current Share Class | 22.08M |
| Shares Outstanding | 22.08M |
| Shares Change (YoY) | +13.83% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 8.33% |
| Owned by Institutions (%) | 68.15% |
| Float | 11.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.26 |
| Forward PS | 12.06 |
| PB Ratio | 9.45 |
| P/TBV Ratio | 9.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.16.
| Current Ratio | 6.10 |
| Quick Ratio | 5.79 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.94 |
Financial Efficiency
Return on equity (ROE) is -80.35% and return on invested capital (ROIC) is -44.57%.
| Return on Equity (ROE) | -80.35% |
| Return on Assets (ROA) | -36.98% |
| Return on Invested Capital (ROIC) | -44.57% |
| Return on Capital Employed (ROCE) | -57.03% |
| Revenue Per Employee | $341,161 |
| Profits Per Employee | -$882,371 |
| Employee Count | 528 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.32% in the last 52 weeks. The beta is -0.41, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | +21.32% |
| 50-Day Moving Average | 333.42 |
| 200-Day Moving Average | 287.36 |
| Relative Strength Index (RSI) | 45.41 |
| Average Volume (20 Days) | 325,764 |
Short Selling Information
The latest short interest is 4.09 million, so 18.54% of the outstanding shares have been sold short.
| Short Interest | 4.09M |
| Short Previous Month | 3.75M |
| Short % of Shares Out | 18.54% |
| Short % of Float | 36.02% |
| Short Ratio (days to cover) | 8.96 |
Income Statement
In the last 12 months, MDGL had revenue of $180.13 million and -$465.89 million in losses. Loss per share was -$21.90.
| Revenue | 180.13M |
| Gross Profit | 173.90M |
| Operating Income | -497.88M |
| Pretax Income | -510.45M |
| Net Income | -465.89M |
| EBITDA | -496.78M |
| EBIT | -497.88M |
| Loss Per Share | -$21.90 |
Full Income StatementBalance Sheet
The company has $926.25 million in cash and $119.57 million in debt, giving a net cash position of $806.68 million or $36.53 per share.
| Cash & Cash Equivalents | 926.25M |
| Total Debt | 119.57M |
| Net Cash | 806.68M |
| Net Cash Per Share | $36.53 |
| Equity (Book Value) | 754.38M |
| Book Value Per Share | 34.28 |
| Working Capital | 863.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$455.57 million and capital expenditures -$1.46 million, giving a free cash flow of -$457.03 million.
| Operating Cash Flow | -455.57M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | -457.03M |
| FCF Per Share | -$20.70 |
Full Cash Flow StatementMargins
Gross margin is 96.54%, with operating and profit margins of -276.39% and -258.64%.
| Gross Margin | 96.54% |
| Operating Margin | -276.39% |
| Pretax Margin | -258.64% |
| Profit Margin | -258.64% |
| EBITDA Margin | -275.78% |
| EBIT Margin | -276.39% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.83% |
| Shareholder Yield | -13.83% |
| Earnings Yield | -6.51% |
| FCF Yield | -6.39% |
Dividend DetailsAnalyst Forecast
The average price target for MDGL is $354.75, which is 9.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $354.75 |
| Price Target Difference | 9.50% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 83.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 8.33 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.33 |
| Piotroski F-Score | 2 |